Papaya preparation (Caricol®) in digestive disorders
Abstract
Objective: Papaya (Carica papaya L.) is used as a natural remedy in abnormal digestion in tropical and industrialized countries. Besides this wide distribution little evidence has been produced with reference to its physiological effect in humans and the proof of efficacy. Former clinical observations had revealed positive effects for patients with constipation, heartburn, and symptoms of irritable bowel syndrome (IBS) after eating papaya preparations. In line with these former positive clinical observations, we studied the clinical effects of the papaya preparation Caricol® in a double blind placebo controlled study design.
Methods: In this study the participants were volunteers, with chronic (prevailing) indigestions and dysfunctions in the gastrointestinal tract. During the trial the intake of the substance of intent and placebo was 20 ml daily for 40 days. The endpoints were the frequency of 22 symptoms recorded before and after the documented intake recorded by questionnaire.
Results: The symptoms "Constipation", "Bloating", and "Heartburn" were defined as primary and frequency of "painful (straining) bowel movements" as secondary endpoint. The participation ended after the intake period within two days ("early returnees"). Wash out effects were observed in "late returnees", who returned with a delay of 8.6 (±5.95 days). In the verum group early returnees revealed statistically significant improvements of the symptoms "constipation" and "bloating". The analysis of "heartburn" felt short of significant improvement because of the small number of included cases with this criteria (N=13, p=0.114). None of the significant benefits were observed after the washout phase.
Conclusion: We conclude from these results, that the papaya preparation (Caricol®) contributes to the maintenance of digestive tract physiology. It ameliorates various functional disturbances, like symptoms of IBS. The mechanism of this digestive tract physiology support is discussed.
Similar articles
Dancey CP, Attree EA, Brown KF.Nutr J. 2006 Jun 8;5:16. doi: 10.1186/1475-2891-5-16.PMID: 16762076 Free PMC article. Clinical Trial.
Tack JF, Miner PB Jr, Fischer L, Harris MS.Aliment Pharmacol Ther. 2011 Oct;34(8):868-77. doi: 10.1111/j.1365-2036.2011.04818.x. Epub 2011 Aug 24.PMID: 21883322 Clinical Trial.
Tack J, Müller-Lissner S, Bytzer P, Corinaldesi R, Chang L, Viegas A, Schnekenbuehl S, Dunger-Baldauf C, Rueegg P.Gut. 2005 Dec;54(12):1707-13. doi: 10.1136/gut.2005.070789. Epub 2005 Jul 14.PMID: 16020489 Free PMC article. Clinical Trial.
A review of the clinical efficacy of linaclotide in irritable bowel syndrome with constipation.
Johnston JM, Shiff SJ, Quigley EM.Curr Med Res Opin. 2013 Feb;29(2):149-60. doi: 10.1185/03007995.2012.754743. Epub 2012 Dec 20.PMID: 23198977 Review.
Uehleke B, Zahradnicek S, Vennos C.Forsch Komplementmed. 2013;20 Suppl 2:8-13. doi: 10.1159/000351139. Epub 2013 Jun 21.PMID: 23860106 Review. German.
See all similar articles
Cited by
Non-Chinese herbal medicines for functional dyspepsia.
Báez G, Vargas C, Arancibia M, Papuzinski C, Franco JV.Cochrane Database Syst Rev. 2023 Jun 15;6(6):CD013323. doi: 10.1002/14651858.CD013323.pub2.PMID: 37323050 Review.
Balmus IM, Copolovici D, Copolovici L, Ciobica A, Gorgan DL.Molecules. 2022 Apr 8;27(8):2403. doi: 10.3390/molecules27082403.PMID: 35458601 Free PMC article. Review.
Schulz RM, Ahuja NK, Slavin JL.Nutrients. 2022 Feb 5;14(3):672. doi: 10.3390/nu14030672.PMID: 35277031 Free PMC article. Review.
Koehler A, Rao R, Rothman Y, Gozal YM, Struve T, Alschuler L, Sengupta S.Integr Cancer Ther. 2022 Jan-Dec;21:15347354211068417. doi: 10.1177/15347354211068417.PMID: 34984951 Free PMC article.
Maito CD, Melo ADB, Oliveira ACDF, Genova JL, Filho JRE, Macedo REF, Monteiro KM, Weber SH, Koppenol A, Costa LB.Anim Biosci. 2022 Jan;35(1):87-95. doi: 10.5713/ab.21.0011. Epub 2021 Jun 23.